Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target
Top Cited Papers
- 4 April 2006
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1762 (11-12), 1051-1067
- https://doi.org/10.1016/j.bbadis.2006.03.008
Abstract
No abstract availableKeywords
This publication has 202 references indexed in Scilit:
- Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron diseaseCochrane Database of Systematic Reviews, 2007
- Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice—a model of familial amyotrophic lateral sclerosisFree Radical Biology & Medicine, 2005
- High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind studyJournal of Neural Transmission, 2004
- Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signalsToxicology, 2004
- Chemoprevention through the Keap1–Nrf2 signaling pathway by phase 2 enzyme inducersMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004
- Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?Trends in Pharmacological Sciences, 1998
- Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosisNeuroscience Letters, 1995
- Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS)Brain Research, 1995
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993